2022 Archive

SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.

Microcephaly is a rare neurodevelopmental condition in which a baby’s head is much smaller than expected because the brain did not develop properly or stopped developing during pregnancy. St. Jude researchers identified cells in the outer radial glia in the developing brain that play an important role in microcephaly.

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.

St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.

St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.

Now is a great time for kids to get vaccinated against HPV and protected against six different cancers.

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.

Stimulating the adaptive immune response can improve outcomes for ALL treated with chemotherapy.

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

HPV vaccination rates dipped during the COVID-19 pandemic. St. Jude is working with more than 100 organizations, health experts and others to highlight vaccination as cancer prevention.